Evidence map›Paper›PMID 35106518›Full record

ReviewClinical nutrition open science2022

Novel antiviral effects of chloroquine, hydroxychloroquine, and green tea catechins against SARS CoV-2 main protease (Mpro) and 3C-like protease for COVID-19 treatment.

Fareeda Begum Shaik, K Swarnalatha, M Chandra Mohan, Anu Thomas, Rajasekhar Chikati, G Sandeep, Narendra Maddu

Open access · goldAbstract readReview
In one paragraph

Review in Clinical nutrition open science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Dietary supplements for the management of COVID-19 symptoms.Journal of preventive medicine and hygiene · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Fareeda Begum ShaikDepartment of Biochemistry, Sri Krishnadevaraya University, Anantapur, 515003, A.P. India.
K SwarnalathaDepartment of Biochemistry, Sri Krishnadevaraya University, Anantapur, 515003, A.P. India.
M Chandra MohanSB Organics Limited, Hyderabad, Telangana, India.
Anu ThomasDepartment of Nursing, Banaswadi College of Nursing, Bangalore, Karnataka, India.
Rajasekhar ChikatiDepartment of Biochemistry, Yogivemana University, Kadapa, 516005, A.P. India.
G SandeepDivision of Molecular Biology, Department of Zoology, Sri Venkateswara University, Tirupati, 517502, A.P, India.
Narendra MadduDepartment of Biochemistry, Sri Krishnadevaraya University, Anantapur, 515003, A.P. India.
Sri Krishnadevaraya University · INSri Venkateswara University · INYogi Vemana University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesCoronaviruses are globally emerging viruses that threaten our health care systems and have become a popular pandemic around the world. This causes a sudden rise in positive coronavirus cases and related deaths to occur worldwide, representing a significant health hazard to humans and the economy.

methodsWe examined predominantly catechins of green tea include epigallocatechin-3-gallate (EGCG), epicatechin-3-gallate (ECG), and drugs of chloroquine (CQ), and hydroxychloroquine (HCQ) appearing to reveal anti-viral activities. Data were collected from PubMed, Google Scholar, and Science Direct databases. To investigate the role of antiviral effects (CQ and HCQ), green tea catechins, beneficial use of convalescent plasma; covaxin in COVID-19 patients faced a dangerous healthiness issue. Computational docking analysis has been used for this purpose.

resultsThe lead compounds are EGCG and ECG act as potential inhibitors bind to the active site region of the HKU4-CoV 3CL protease and M-Pro protease enzymes of coronavirus.

Indexed as

ChloroquineConvalescent plasma therapyCovaxinCOVID 19Green teaHydroxychloroquine

Identifiers

PMID35106518
PMCPMC8795779
OpenAlexW4210700192

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.